23Jan
Blog: Cooley's 2019 Life Sciences M&A Year in Review
2019 was a banner year for billion-dollar life sciences M&A transactions. A wave of big-ticket transactions by global pharmaceutical companies drove life sciences M&A activity to its fourth-largest year on record in 2019, with aggregate deal value in...
By:
Cooley LLP
Related
In Stanley Kubrick’s 1968 epic 2001: A Space Odyssey, HAL 9000, a fictional artificial intelligence...
Read More >
Lawyers love to follow the intricacies of litigation - we read the court decisions and follow matter...
Read More >
On November 27, 2019, the U.S. Department of Commerce (Commerce) published a proposed rule that woul...
Read More >
In today’s edition of Daily Compliance News: • How is employee activism different than CEO activi...
Read More >
The creation of the new movie “Bombshell” has brought up interesting questions when it comes to no...
Read More >
How a transaction gets structured raises a multitude of issues, including whether the transaction mi...
Read More >